IDXX Stock Up 10% after 6-Day Win Streak
IDEXX Laboratories (IDXX) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 10% return. The company has gained about $4.6 Bil in value over the last 6 days, with its current market capitalization at about $46 Bil. The stock remains 37.0% above its value at the end of 2024. This compares with year-to-date returns of 8.6% for the S&P 500.
Comparing IDXX Stock Returns With The S&P 500
The following table summarizes the return for IDXX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | IDXX | S&P 500 |
|---|---|---|
| 1D | 0.2% | 0.0% |
| 6D (Current Streak) | 10.1% | 1.5% |
| 1M (21D) | 7.3% | 4.1% |
| 3M (63D) | 29.5% | 15.6% |
| YTD 2025 | 37.0% | 8.6% |
| 2024 | -25.5% | 23.3% |
| 2023 | 36.1% | 24.2% |
| 2022 | -38.0% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
- AST SpaceMobile: Is This Starlink Rival Stock Poised To Soar Higher?
- Where Is Alphabet Stock Headed?
- How To Earn 8.2% Yield While Waiting to Buy WYNN 30% Cheaper
- What Could Light a Fire Under Costco Wholesale Stock
- The Hidden Dangers Facing Amazon.com Stock
- Cash Rich, Low Price – Ardent Health Stock to Break Out?
There are currently 42 S&P constituents with 3 days or more of consecutive gains and 69 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 9 | 47 |
| 4D | 12 | 20 |
| 5D | 10 | 1 |
| 6D | 7 | 1 |
| 7D or more | 4 | 0 |
| Total >=3 D | 42 | 69 |
Key Financials for IDEXX Laboratories (IDXX)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $3.7 Bil | $3.9 Bil |
| Operating Income | $1.1 Bil | $1.1 Bil |
| Net Income | $845.0 Mil | $887.9 Mil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $954.3 Mil | $998.4 Mil |
| Operating Income | $261.7 Mil | $316.5 Mil |
| Net Income | $216.1 Mil | $242.7 Mil |
While IDXX stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.